Horizon 2020

News

A new EU-funded project called In Silico World aims to encourage the use of simulation for drug and medical device development.

News

Money comes from Horizon 2020 fund.

News

Hengrui's oral TPO agonist, hetrombopag, is the first in the class to be approved for thrombocytopenia caused by chemotherapy for solid tumours.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.